Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Three Spectrophotometric Methods for Quantitative Analysis of Duloxetine in Presence of its Toxic Impurity: 1-Naphthol

View through CrossRef
AbstractBackgroundDuloxetine hydrochloride (DUL) is a drug used to treat depression and anxiety. 1-Naphthol is a potential toxic impurity of DUL, as it causes hepatotoxicity in humans, and it is harmful to aquatic life.ObjectiveThree simple, selective, rapid, accurate and precise methods were developed and validated according to International Conference on Harmonization (ICH) guidelines with respect to linearity, accuracy, precision and selectivity for analysis of duloxetine hydrochloride (DUL) in the presence of its potential toxic impurity 1-Naphthol in different laboratory-prepared mixtures and pharmaceutical formulations.MethodsMethod (A) is the first derivative of the ratio spectra spectrophotometric (1DD) method which allows determination of DUL at 251 nm and 1-Naphthol at 305.2 nm without interference from each other. Method B (dual wavelength) means that two different wavelengths were chosen to each drug, where the absorbance difference at these two wavelengths is equal to zero to the second drug. The chosen two wavelengths for DUL were 221.4 nm and 235.6, where the absorbance difference for 1-naphthol at these two wavelengths was equal to zero. While the chosen wavelengths for 1-naphthol were 247.8 nm and 297 nm, where the absorbance difference for DUL at these two wavelengths was equal to zero. Method (C) is the mean centering of ratio spectra spectrophotometric (MCR) method, which depends on measuring the mean centered values of ratio spectra of both DUL and 1-Naphthol at 226 nm.ResultsThese methods were validated and agreed with the requirements of ICH guidelines with respect to linearity, accuracy, precision and selectivity.ConclusionsThe results indicate the ability of developed methods to be used for routine quality control analysis of DUL in bulk and pharmaceutical formulations in the presence of its potential impurity 1-Naphthol.
Title: Three Spectrophotometric Methods for Quantitative Analysis of Duloxetine in Presence of its Toxic Impurity: 1-Naphthol
Description:
AbstractBackgroundDuloxetine hydrochloride (DUL) is a drug used to treat depression and anxiety.
1-Naphthol is a potential toxic impurity of DUL, as it causes hepatotoxicity in humans, and it is harmful to aquatic life.
ObjectiveThree simple, selective, rapid, accurate and precise methods were developed and validated according to International Conference on Harmonization (ICH) guidelines with respect to linearity, accuracy, precision and selectivity for analysis of duloxetine hydrochloride (DUL) in the presence of its potential toxic impurity 1-Naphthol in different laboratory-prepared mixtures and pharmaceutical formulations.
MethodsMethod (A) is the first derivative of the ratio spectra spectrophotometric (1DD) method which allows determination of DUL at 251 nm and 1-Naphthol at 305.
2 nm without interference from each other.
Method B (dual wavelength) means that two different wavelengths were chosen to each drug, where the absorbance difference at these two wavelengths is equal to zero to the second drug.
The chosen two wavelengths for DUL were 221.
4 nm and 235.
6, where the absorbance difference for 1-naphthol at these two wavelengths was equal to zero.
While the chosen wavelengths for 1-naphthol were 247.
8 nm and 297 nm, where the absorbance difference for DUL at these two wavelengths was equal to zero.
Method (C) is the mean centering of ratio spectra spectrophotometric (MCR) method, which depends on measuring the mean centered values of ratio spectra of both DUL and 1-Naphthol at 226 nm.
ResultsThese methods were validated and agreed with the requirements of ICH guidelines with respect to linearity, accuracy, precision and selectivity.
ConclusionsThe results indicate the ability of developed methods to be used for routine quality control analysis of DUL in bulk and pharmaceutical formulations in the presence of its potential impurity 1-Naphthol.

Related Results

Dose–Concentration Relationship and Clinical Outcomes of Duloxetine in Generalized Anxiety Disorder
Dose–Concentration Relationship and Clinical Outcomes of Duloxetine in Generalized Anxiety Disorder
Background/Objectives: This study aimed to investigate plasma duloxetine concentrations, factors influencing these concentrations, and the relationship between plasma levels and cl...
COMPARISON OF DULOXETINE MONOTHERAPY VERSUS DULOXETINE AND GABAPENTIN COMBINATION THERAPY FOR NEUROPATHIC PAIN RELIEF
COMPARISON OF DULOXETINE MONOTHERAPY VERSUS DULOXETINE AND GABAPENTIN COMBINATION THERAPY FOR NEUROPATHIC PAIN RELIEF
Background: Neuropathic pain is a complex and often refractory condition that significantly impairs quality of life. Pharmacological management remains the cornerstone of treatment...
Duloxetine for the Treatment of Major Depressive Disorder
Duloxetine for the Treatment of Major Depressive Disorder
Background. Existing therapies for depression frequently fail to provide full remission. This report evaluates the efficacy and safety of duloxetine, a dual reuptake inhibitor of s...
Acute generalized exanthematous pustulosis induced by duloxetine
Acute generalized exanthematous pustulosis induced by duloxetine
AbstractDuloxetine is a serotonin and norepinephrine reuptake inhibitor. Some rare duloxetine‐induced hypersensitivity skin reactions have been reported. We report a case of acute ...
Impact of Polymorphism of CYP2D6 on Equilibrium Concentration of Duloxetine in Patients Suffering from Major Depressive Disorder
Impact of Polymorphism of CYP2D6 on Equilibrium Concentration of Duloxetine in Patients Suffering from Major Depressive Disorder
Introduction Duloxetine is commonly prescribed to patients with recurrent depressive disorder. Some part of patients in this group do not respond adequately to treatment regimen co...

Back to Top